Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Where is the genetics industry headed?

The company to offer the first thousand dollar genome claims it will soon have a monopoly in genetics to rival that of Amazon in retail. In doing so, could Veritas Genetics finally deliver on the false promises of the industry and revolutionise healthcare as a whole? 

Greece – recovery or zombie apocalypse?

We hear that the debt of Euromedica, the Greek diagnostics chain, is being bid for. So what is the situation at the big three Greek hospital groups and Bioiatriki, the labs to hospital outfit? And is there any sign of better times?

Medicover targets Indian expansion following Q3 results

Listed pan-European healthcare and medical laboratory services provider Medicover saw its share price dip slightly, by 1.5%, as third quarter results were announced, despite a 16% jump in revenues and a 20% increase in EBITDA. India was announced as a key target for expansion, while Eastern European operations saw particularly strong growth.

Mexican pharmacy chains power into primary care

Mexico's big pharmacy chains are powering into primary care which they see as a good way to sell more prescriptions. They could already be doing as many 500,000 primary care consultations a day according to Chief Innovation Officer Carlos Perez at Proa, the largest private lab group in Mexico who was speaking at Healthcare Latam, the inaugural Pan-Latin American healthcare service event.

Brazil: Problems and Opportunities

Here we look at the Brazilian private healthcare services market.  What is the potential in what is, per capita, the world's second largest private medical insurance market? 

For-profit medical education – a survey

Public sector education is failing to build the nursing and doctor capacity that is needed around the world.  We talk to academic Kevin Kinser at PennState University in the USA who specialises in tracking the for-profit tertiary education sector about the sector in general and about healthcare specifically.  This is part of a series of articles on medical training and the private sector. 

Alliar hopes for giant PPP contract

Imaging and lab group Alliar has its eyes on another giant Private Public partnership (PPP) contract in Brazil which would be twice as big as its US$60m a year, 11.5 year contract with Bahia state, says CEO Fernando Termi, speaking at the inaugural Healthcare Latam conference.

Find Us